Following evaluation by our multidisciplinary team, robot-assisted bronchoscopy (RAB) was performed, revealing three distinct primary malignancies: well-differentiated adenocarcinoma with KRAS mutation, poorly differentiated adenocarcinoma with EGFR mutation, and a well-differentiated carcinoid tumor. The gene discussed is EGFR; the disease is carcinoid tumor.